Variable | Pre-pandemic assessment (N = 342) | During pandemic assessment (N = 342) | ||||||
---|---|---|---|---|---|---|---|---|
RHS-15 Part Ia | p-value* | RHS-15 Part IIa | p-value* | RHS-15 Part Ia | p-value | RHS-15 Part IIa | p-value* | |
Total score | ||||||||
Mean ± SD | 22.96 ± 8.43 | 4.42 ± 1.59 | 46.72 ± 1.87 | 6.91 ± 1.49 | ||||
Median (Min–Max) | 23 (2–44) | 5 (0–10) | 47 (40–51) | 7 (4–10) | ||||
Age category (years) | ||||||||
≤ 30 | 21.94 ± 8.34 | 0.005 | 4.43 ± 1.59 | 0.980 | 46.57 ± 1.84 | 0.052 | 6.89 ± 1.47 | 0.766 |
> 30 | 24 .53 ± 8.35 | 4.43 ± 1.59 | 46.97 ± 1.88 | 6.94 ± 1.51 | ||||
Gender | ||||||||
Female | 22.71 ± 8.23 | 0.486 | 4.51 ± 1.54 | 0.244 | 46.89 ± 1.74 | 0.033 | 7.28 ± 1.40 | < 0.001 |
Male | 23.36 ± 8.74 | 4.30 ± 1.67 | 46.45 ± 2.02 | 6.33 ± 1.44 | ||||
Marital status | ||||||||
Married | 23.38 ± 8.29 | 0.134 | 4.48 ± 1.47 | 0.320 | 46.76 ± 1.83 | 0.585 | 6.91 ± 1.51 | 0.984 |
Singleb | 21.85 ± 8.71 | 4.28 ± 1.88 | 46.64 ± 1.96 | 6.91 ± 1.45 | ||||
Comorbidities | ||||||||
HTN | ||||||||
Present | 21.66 ± 8.28 | 0.061 | 4.42 ± 1.39 | 0.943 | 46.63 ± 2.04 | 0.529 | 7.15 ± 0.14 | 0.057 |
Absent | 23.52 ± 8.44 | 4.43 ± 1.68 | 46.77 ± 1.79 | 6.81 ± 1.51 | ||||
BA | ||||||||
Present | 22.65 ± 8.91 | 0.827 | 4.06 ± 1.99 | 0.185 | 47.00 ± 1.48 | 0.396 | 6.74 ± 1.59 | 0.505 |
Absent | 22.99 ± 8.39 | 4.46 ± 1.55 | 46.70 ± 1.87 | 6.92 ± 1.48 | ||||
IHD | ||||||||
Present | 25.40 ± 6.94 | 0.021 | 4.24 ± 1.72 | 0.414 | 46.30 ± 2.21 | 0.121 | 6.91 ± 1.51 | 0.486 |
Absent | 22.62 ± 8.57 | 4.45 ± 1.58 | 46.79 ± 1.81 | 6.93 ± 1.51 | ||||
COPD | ||||||||
Present | 23.14 ± 7.71 | 0.906 | 4.57 ± 1.91 | 0.618 | 46.74 ± 1.88 | 0.801 | 6.43 ± 1.69 | 0.073 |
Absent | 22.95 ± 8.49 | 4.41 ± 1.57 | 46.64 ± 1.70 | 6.96 ± 1.47 | ||||
DM | ||||||||
Present | 26.70 ± 4.90 | 0.003 | 4.50 ± 0.82 | 0.709 | 47.40 ± 1.14 | 0.097 | 7.90 ± 0.96 | < 0.001 |
Absent | 22.73 ± 8.56 | 4.42 ± 1.63 | 46.69 ± 1.89 | 6.85 ± 1.49 |